ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2023

Cardiac safety profile of type II kinase inhibitors: Analysis of post-marketing reports from databases of European Medicine Agency & World Health Organization.

Atul Khurana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.